BIOTA PHARMACEUTIALS INC's ticker is BOTA and the CUSIP is 090694100. A total of 46 filers reported holding BIOTA PHARMACEUTIALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $20,000 | -35.5% | 13,142 | -17.3% | 0.00% | 0.0% |
| Q4 2015 | $31,000 | +24.0% | 15,892 | +27.8% | 0.00% | – |
| Q3 2015 | $25,000 | -41.9% | 12,433 | -39.9% | 0.00% | -100.0% |
| Q2 2015 | $43,000 | -10.4% | 20,681 | -1.4% | 0.00% | 0.0% |
| Q1 2015 | $48,000 | +41.2% | 20,974 | +38.8% | 0.00% | 0.0% |
| Q4 2014 | $34,000 | -38.2% | 15,114 | -22.0% | 0.00% | 0.0% |
| Q2 2014 | $55,000 | – | 19,367 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENZAR ASSET MANAGEMENT, LLC | 1,617,500 | $3,348,000 | 0.58% |
| Broadfin Capital, LLC | 2,611,711 | $5,406,000 | 0.29% |
| RA Capital Management | 807,855 | $1,672,000 | 0.17% |
| TOWERVIEW LLC | 160,000 | $331,000 | 0.16% |
| BVF INC/IL | 350,776 | $726,000 | 0.13% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 292,807 | $606,000 | 0.09% |
| Koshinski Asset Management, Inc. | 27,200 | $28,180,000 | 0.02% |
| Baker Brothers Advisors | 830,440 | $1,719,000 | 0.02% |
| KNOTT DAVID M | 31,833 | $65,894,000 | 0.01% |
| SHEPHERD KAPLAN KROCHUK, LLC | 26,756 | $55,000 | 0.01% |